CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Duke University
University of Nebraska
Rutgers, The State University of New Jersey
University of Pennsylvania
Samus Therapeutics, Inc.
Beijing Boren Hospital
Weill Medical College of Cornell University
University of Pennsylvania
Hoffmann-La Roche
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
New York Blood Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dartmouth-Hitchcock Medical Center
Indiana University
University of California, San Francisco